Journal of Nursing ›› 2023, Vol. 30 ›› Issue (11): 59-64.doi: 10.16460/j.issn1008-9969.2023.11.059
Previous Articles Next Articles
Predictive power comparison of three different risk assessment models for symptomatic peripherally inserted central catheter related venous thromboembolism among patients with acute myeloblastic leukemia
XU Hui-juan, LIU Ying, YAO Jia-li, YAO Jing-jing, CHEN Min, QIU Tian-tian, XU Dan
- Dept. of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
CLC Number:
- R473.55
| [1] Ren Y, Chang L, Zhao B, et al.Venous Thromboembolism after peripherally inserted central catheters placement in children with acute leukemia: a single-center retrospective cohort study[J]. J Pediatr Hematol Oncol,2020, 42(6):e407-e409. DOI: 10.1097/MPH.0000000000001832. [2] Lee YG, Kim I, Kwon JH, et al.Implications of cytogenetics for venous thromboembolism in acute myeloid leukaemia[J]. Thromb Haemost, 2015,113(1):201-208.DOI:10.1160/TH13-12-1020. [3] 国际血管联盟中国分会,中国老年医学学会周围血管疾病管理分会.输液导管相关静脉血栓形成防治中国专家共识(2020版)[J].中国实用外科杂志, 2020, 40(4):377-383.DOI:10.19538/j.cjps.issn1005-2208.2020.04.03. [4] Gorski LA, Hadaway L, Hagle ME, et al.Infusion therapy standards of practice[J]. [J] Infus Nurs. 2021, 44(s1):S1-S224. DOI:10.1097/NAN.0000000000000396. [5] Sriskandarajah P, Webb K, Chisholm D, et al.Retrospective cohort analysis comparing the incidence of deep vein thromboses between peripherally-inserted and long-term skin tunneled venous catheters in hemato-oncology patients[J]. Thromb J,2015,25:13-21.DOI:10.1186/s12959-015-0052-2. [6] Ban T, Fujiwara S I, Rui M, et al.Risk factors for complications associated with peripherally inserted central catheters during induction chemotherapy for acute myeloid leukemia[J]. Intern Med,2022,61(7):989-995.DOI:10.2169/internalmedicine.8184-21. [7] Bruzzese A, Chistolini A, Morano SG, et al.Peripherally inserted central catheter in patients with acute myeloid leukemia: incidence and risk factors for premature removal[J]. Leuk Lymphoma,2020,61(9):2265-2267. DOI: 10.1080/10428194.2020.1762880. [8] Del Principe MI, Buccisano F, Maurillo L, et al.Infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia[J]. Thromb Res, 2013,132(5):511-514. DOI: 10.1016/j.thromres.2013.08.007. [9] Lim MY, Al-Kali A, Ashrani AA, et al.Comparison of complication rates of hickman( ) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy[J].Leuk Lymphoma,2013, 54(6):1263-1267.DOI:10.3109/10428194.2012.742520. [10] McKeown C, Ricciuti A, Agha M, et al. A Prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy[J].Support Care Cancer, 2022,30(2):1673-1679.DOI: 10.1007/s00520-021-06339-x. [11] Picardi M, Della Pepa R, Cerchione C, et al.A frontline approach with peripherally inserted versus centrally inserted central venous catheters for remission induction chemotherapy phase of acute myeloid leukemia: a randomized comparison[J]. Clin Lymphoma Myeloma Leuk,2019, 19(4):e184-e194. DOI: 10.1016/j.clml.2018.12.008. [12] 李钱玲,唐玮,李冬雪,等. Caprini风险评估模型评估肿瘤患者PICC相关静脉血栓的有效性研究[J].重庆医科大学学报,2019, 44(7):959-964.DOI:10.13406/j.cnki.cyxb.002199. [13] Feng Y, Zheng R, Fu Y, et al.Assessing the thrombosis risk of peripherally inserted central catheters in cancer patients using caprini risk assessment model: a prospective cohort study[J]. Support Care Cancer, 2021, 29(9):5047-5055. DOI: 10.1007/s00520-021-06073-4. [14] 李钱玲,甘秀妮,李源,等. Autar量表与Caprini评估模型对肿瘤患者PICC相关静脉血栓形成预测效果的对比研究[J].护理学报, 2019,26(22):1-5.DOI:10.16460/j.issn1008-9969.2019.22.001. [15] 朱薇,应燕萍,黄惠桥,等. 三种评分表预测PICC相关上肢深静脉血栓效果比较研究[J]. 护理学杂志, 2018,33(7):54-56. DOI:10.3870/j.issn.1001-4152.2018.07.054. [16] 万光明. Autar量表在肺癌患者经外周静脉置入中心静脉导管相关上肢静脉血栓形成风险评估中的应用[J]. 中华临床营养杂志,2016,24(6):376-379. DOI:10.3760/cma.j.issn.1674-635X.2016.06.010. [17] 张亚,岳静,米爱,等. 血液肿瘤患者经外周静脉置入中心静脉导管相关性血栓的临床研究[J]. 四川医学,2022,43(6):593-597. DOI:10.16252/j.cnki.issn1004-0501-2022.06.014. [18] O'Donnell MR, Tallman MS, Abboud CN, et al. Acute myeloid leukemia, version 3.2017, nccn clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2017,15(7):926-957. DOI:10.6004/jnccn.2017.0116. [19] 李峥,刘宇. 护理学研究方法[M]. 北京:人民卫生出版社,2012. [20] Caprini JA, Arcelus JI, Hasty JH, et al.Clinical assessment of venous thromboembolic risk in surgical patients[J]. Semin Thromb Hemost, 1991, 17(Suppl 3):304-312. [21] Caprini JA.Thrombosis risk assessment as a guide to quality patient care[J]. Dis Mon, 2005, 51(2-3):70-78. DOI: 10.1016/j.disamonth.2005.02.003. [22] Bahl V, Hu HM, Henke PK, et al.A Validation study of a retrospective venous thromboembolism risk scoring method[J]. Ann Surg, 2010, 251(2):344-350. DOI: 10.1097/SLA.0b013e3181b7fca6. [23] 刘芯言,云洁,吴琪,等. Caprini血栓风险评估表对肿瘤病人静脉血栓栓塞症诊断价值的Meta分析[J]. 护理研究,2022,36(10):1764-1770. DOI:10.12102/j.issn.1009-6493.2022.10.012. [24] Barbar S, Noventa F, Rossetto V, et al.A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score[J]. J Thromb Haemost, 2010, 8(11):2450-2457. DOI: 10.1111/j.1538-7836.2010.04044.x. [25] Kahn SR, Lim W, Dunn AS, et al.Prevention of VTE in nonsurgical patients: anti-thrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines[J]. Chest, 2012, 141(2):e195S-e226s. DOI:10.1378/CHEST.11-2296. [26] 《中国血栓性疾病防治指南》专家委员会. 中国血栓性疾病防治指南[J]. 中华医学杂志, 2018, 98(36):2861-2888. DOI:10.3760/cma.j.issn.0376-2491.2018.36.002. [27] Autar R.Nursing assessment of clients at risk of deep vein thrombosis (DVT): the Autar DVT Scale[J]. J Adv Nur, 1996,23(4):763-770.DOI:10.1111/j.1365-2648.1996.tb00049.x [28] Jones D, Wismayer K, Bozas G, et al.The risk of venous thromboembolism associated with peripherally inserted central catheters in ambulant cancer patients[J]. Thromb J, 2017, 15(1):25. DOI:10.1186/s12959-017-0148-y. [29] 李乾, 赵欣, 张晓维, 等. 国内成人肿瘤患者PICC相关性血栓发生率的Meta分析[J]. 中华护理杂志, 2022, 57(3): 348-355. DOI:10.3761/j.issn.0254-1769.2022.03.016. [30] Bhargava M, Broccard S, Bai Y, et al.Risk factors for peripherally inserted central catheter line related deep venous thrombosis in critically ill intensive care unit patients[J]. SAGE Open Medicine, 2020, 8:205031212092923. DOI: 10.1177/2050312120929238. [31] Schiffer CA.Hyperleukocytosis and Leukostasis in Hematologic Malignancies[EB/OL].[2022-06-09].https://www.uptodate.cn/contents/zh-Hans/hyperleukocytosis-and-leukostasis-in-hematologic-malignancies. [32] Del Principe MI, Del Principe D, Venditti A.Thrombosis in adult patients with acute leukemia[J]. Curr Opin Oncol, 2017,29(6):448-454.DOI:10.1097/CCO.0000000000000402. [33] Morano SG, Latagliata R, Girmenia C, et al.Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC)[J]. Support Care Cancer, 2015, 23(11):3289-3295. DOI: 10.1007/s00520-015-2740-7. [34] 陈卫中,倪宗瓒,潘晓平,等. 用ROC曲线确定最佳临界点和可疑值范围[J]. 现代预防医学, 2005,32(7):729-731. DOI:10.3969/j.issn.1003-8507.2005.07.010. [35] Lin Y, Zeng Z, Lin R, et al.The caprini thrombosis risk model predicts the risk of peripherally inserted central catheter-related upper extremity venous thrombosis in patients with cancer[J]. J Vasc Surg Venous Lymphat Disord, 2021, 9(5):1151-1158. DOI: 10.1016/j.jvsv.2020.12.075. [36] 马平,宋华. 血液肿瘤患者PICC导管相关性血栓发生原因与预防研究进展[J]. 中国护理管理,2019,19(2):301-305. DOI:10.3969/j.issn.1672-1756.2019.02.029. |
| [1] | LI Qian-ling, GAN Xiu-ni, LI Yuan, TANG Wei. Comparison of Predictive Power for PICC-related Venous Thromboembolism among Cancer Patients of Autar DVT Risk Assessment Scale and Caprini Risk Assessment Scale [J]. Journal of Nursing, 2019, 26(22): 1-5. |
|